LGALS3 and inflammatory bowel disease: Taken together, these results provide preliminary evidence that serum measurements of periostin and galectin-3 may serve as an adjunct to routine diagnostic methods, potentially improving the sensitivity and specificity not only IBD diagnosis, but also disease activity monitoring and assessment of therapeutic response.